ENvue Medical, Inc. (FEED) Free cash flow
- Free cash flow · 12 months (USD): Value $-11.74M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value -609.76%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-11.74M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $-11.65M − $95.00K ≈ $-11.74M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | -609.76% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $-11.74M ÷ $1.93M × 100 ≈ -609.76% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-11.65M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 0.55× | Operating cash flow / net income. Period ending 2026-06-30. $-11.65M ÷ $-21.06M ≈ 0.55× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -11.65M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 95.00K USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -11.74M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 1.93M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -21.06M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $-11.74M | (m) | $-11.65M | $95.00K | (m) | $1.93M | (m) | $-21.06M | (m) | (m) | -609.76% | 0.55× |
| 2026-03-31 | $-12.41M | (m) | $-12.34M | $72.00K | (m) | $2.18M | (m) | $-20.14M | (m) | (m) | -569.14% | 0.61× |
| 2025-12-31 | $-9.43M | (m) | $-9.37M | $60.00K | (m) | $2.55M | (m) | $-18.18M | (m) | (m) | -369.45% | 0.52× |
| 2025-09-30 | $-7.28M | (m) | $-7.24M | $37.00K | (m) | $2.69M | (m) | $-6.76M | (m) | (m) | -271.17% | 1.07× |
| 2025-06-30 | $-6.12M | (m) | $-6.11M | $9.00K | (m) | $2.34M | (m) | $-8.27M | (m) | (m) | -261.61% | 0.74× |
| 2025-03-31 | $-3.29M | (m) | $-3.28M | $7.00K | (m) | $2.66M | (m) | $-5.61M | (m) | (m) | -123.48% | 0.58× |
| 2024-12-31 | $-2.52M | (m) | $-2.52M | $3.00K | (m) | $2.56M | (m) | $-3.71M | (m) | (m) | -98.48% | 0.68× |
| 2024-09-30 | $-2.46M | (m) | $-2.46M | $3.00K | (m) | $3.29M | (m) | $-3.09M | (m) | (m) | -74.81% | 0.80× |
| 2024-06-30 | $-2.31M | (m) | $-2.31M | $3.00K | (m) | $3.37M | (m) | $-2.82M | (m) | (m) | -68.43% | 0.82× |
| 2024-03-31 | $-2.98M | (m) | $-2.98M | $1.00K | (m) | $2.85M | (m) | $-3.20M | (m) | (m) | -104.63% | 0.93× |
| 2023-12-31 | $-3.60M | (m) | $-3.60M | $1.00K | (m) | $2.28M | (m) | $-3.71M | (m) | (m) | -157.82% | 0.97× |
| 2023-09-30 | $-4.44M | (m) | $-4.44M | $0.00 | (m) | $1.00M | (m) | $-4.96M | (m) | (m) | -442.43% | 0.90× |
| 2023-06-30 | $-5.73M | (m) | $-5.72M | $2.00K | (m) | $643.00K | (m) | $-5.18M | (m) | (m) | -890.51% | 1.10× |
| 2023-03-31 | (m) | (m) | $-6.49M | (m) | (m) | $834.00K | (m) | $-5.41M | (m) | (m) | (m) | 1.20× |
| 2022-12-31 | $-7.04M | (m) | $-7.04M | $3.00K | (m) | $752.00K | (m) | $-5.45M | (m) | (m) | -935.90% | 1.29× |
| 2022-09-30 | $-6.57M | (m) | $-6.57M | $4.00K | (m) | $1.63M | (m) | $-5.86M | (m) | (m) | -403.38% | 1.12× |
| 2022-06-30 | $-5.24M | (m) | $-5.24M | $3.00K | (m) | $2.03M | (m) | $-11.58M | (m) | (m) | -258.00% | 0.45× |
| 2022-03-31 | (m) | (m) | $-5.15M | (m) | (m) | $1.86M | (m) | $-10.50M | (m) | (m) | (m) | 0.49× |
| 2021-12-31 | $-4.37M | (m) | $-4.37M | $3.00K | (m) | $1.70M | (m) | $-14.28M | (m) | (m) | -257.82% | 0.31× |
| 2021-09-30 | (m) | (m) | $-4.82M | (m) | (m) | $1.01M | (m) | $-12.81M | (m) | (m) | (m) | 0.38× |
| 2021-06-30 | (m) | (m) | $-4.88M | (m) | (m) | $661.00K | (m) | $-7.06M | (m) | (m) | (m) | 0.69× |
| 2021-03-31 | (m) | (m) | $-3.45M | (m) | (m) | $612.00K | (m) | $-8.32M | (m) | (m) | (m) | 0.41× |
| 2020-12-31 | $-3.39M | (m) | $-3.39M | $2.00K | (m) | $623.00K | (m) | $-4.33M | (m) | (m) | -544.62% | 0.78× |
| 2020-09-30 | (m) | (m) | $-3.10M | (m) | (m) | $620.00K | (m) | $-4.51M | (m) | (m) | (m) | 0.69× |
| 2020-06-30 | (m) | (m) | $-3.52M | (m) | (m) | $571.00K | (m) | $-4.41M | (m) | (m) | (m) | 0.80× |
| 2020-03-31 | (m) | (m) | $-3.83M | (m) | (m) | $565.00K | (m) | $-4.04M | (m) | (m) | (m) | 0.95× |
| 2019-12-31 | (m) | (m) | $-3.87M | (m) | (m) | $530.00K | (m) | $-5.79M | (m) | (m) | (m) | 0.67× |
| 2019-09-30 | (m) | (m) | $-3.72M | (m) | (m) | $497.00K | (m) | $-5.80M | (m) | (m) | (m) | 0.64× |
| 2019-06-30 | (m) | (m) | $-3.41M | (m) | (m) | $451.00K | (m) | $-6.31M | (m) | (m) | (m) | 0.54× |
| 2019-03-31 | (m) | (m) | $-3.62M | (m) | (m) | $320.00K | (m) | $-6.04M | (m) | (m) | (m) | 0.60× |
| 2018-12-31 | $-3.56M | (m) | $-3.55M | $8.00K | (m) | $318.00K | (m) | $-4.15M | (m) | (m) | -1118.87% | 0.85× |
| 2018-09-30 | (m) | (m) | $-3.45M | (m) | (m) | $334.00K | (m) | $-4.60M | (m) | (m) | (m) | 0.75× |
| 2018-06-30 | (m) | (m) | $-3.13M | (m) | (m) | $344.00K | (m) | $-4.85M | (m) | (m) | (m) | 0.65× |
| 2018-03-31 | (m) | (m) | $-2.64M | (m) | (m) | $264.00K | (m) | $-4.88M | (m) | (m) | (m) | 0.54× |
| 2017-12-31 | (m) | (m) | $-2.18M | (m) | (m) | $239.00K | (m) | $-4.96M | (m) | (m) | (m) | 0.44× |
| 2017-09-30 | $-1.83M | (m) | $-1.83M | $2.00K | (m) | $218.00K | (m) | $-4.44M | (m) | (m) | -839.45% | 0.41× |
| 2017-06-30 | $-1.61M | (m) | $-1.61M | $2.00K | (m) | $214.00K | (m) | $-3.45M | (m) | (m) | -754.21% | 0.47× |
| 2017-03-31 | $-1.58M | (m) | $-1.58M | $1.00K | (m) | $224.00K | (m) | $-3.21M | (m) | (m) | -704.02% | 0.49× |
| 2016-12-31 | $-1.54M | (m) | $-1.53M | $8.00K | (m) | $229.00K | (m) | $-2.83M | (m) | (m) | -672.93% | 0.54× |
| 2016-09-30 | $-1.50M | (m) | $-1.49M | $8.00K | (m) | $219.00K | (m) | $-2.49M | (m) | (m) | -682.65% | 0.60× |
| 2016-06-30 | $-1.49M | (m) | $-1.48M | $8.00K | (m) | $198.00K | (m) | $-2.92M | (m) | (m) | -753.54% | 0.51× |
| 2016-03-31 | $-1.55M | (m) | $-1.54M | $8.00K | (m) | $175.00K | (m) | $-2.75M | (m) | (m) | -886.29% | 0.56× |
| 2015-12-31 | $-1.48M | (m) | $-1.48M | $1.00K | (m) | $147.00K | (m) | $-2.88M | (m) | (m) | -1007.48% | 0.51× |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-904.00K | (m) | $-900.00K | $4.00K | (m) | $203.00K | (m) | $-2.65M | (m) | (m) | -445.32% | 0.34× |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |